Published in N Engl J Med on April 18, 1991
Study of Inherited Changes of Receptors Located on Blood Vessels | NCT00001741
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest (2000) 6.84
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest (1996) 6.38
Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78
Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation (2008) 2.22
Protecting against vascular disease in brain. Am J Physiol Heart Circ Physiol (2011) 1.66
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension (2005) 1.60
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest (1996) 1.54
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care (2009) 1.33
Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest (1996) 1.32
The renin angiotensin system and the metabolic syndrome. Physiol Behav (2010) 1.25
Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest (1993) 1.12
Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ (1994) 1.10
Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. J Hypertens (2011) 1.00
Metabolic rate regulation by the renin-angiotensin system: brain vs. body. Pflugers Arch (2012) 0.99
New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev (2012) 0.98
Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol (2009) 0.97
The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology (2009) 0.95
Evidence based cardiology: emerging approaches in preventing cardiovascular disease. BMJ (1999) 0.94
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc Health Risk Manag (2008) 0.90
Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials. Ther Adv Chronic Dis (2013) 0.88
Academic medicine and the workplace. Am J Public Health (1993) 0.88
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. Postgrad Med J (1994) 0.86
Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis. Horm Metab Res (2008) 0.85
Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis. Am J Hypertens (2014) 0.84
Dietary Sodium Suppresses Digestive Efficiency via the Renin-Angiotensin System. Sci Rep (2015) 0.84
Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element. Hypertension (2001) 0.84
Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats. J Am Heart Assoc (2014) 0.83
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. Am J Hypertens (2014) 0.82
Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease. Drugs (1994) 0.81
Targeting cardiovascular protection: the concept of dual renin-angiotensin system control. Medscape J Med (2008) 0.80
Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death. Heart (2005) 0.80
The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf (2015) 0.80
Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view. Heart (1996) 0.79
Determinants of plasma renin activity: role of a human renin gene variant as a genetic factor. Medicine (Baltimore) (2014) 0.79
Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone. J Vet Intern Med (2014) 0.79
Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Cell Death Dis (2013) 0.79
Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo. Br J Pharmacol (2001) 0.78
Electroacupuncture improves cerebral blood flow and attenuates moderate ischemic injury via Angiotensin II its receptors-mediated mechanism in rats. BMC Complement Altern Med (2014) 0.78
Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure. Kidney Res Clin Pract (2016) 0.77
Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study. J Hum Hypertens (2015) 0.77
Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens (2011) 0.77
Making Sense of the Science of Sodium. Nutr Today (2015) 0.77
High sodium intake: review of recent issues on its association with cardiovascular events and measurement methods. Korean Circ J (2015) 0.77
Role of ACE inhibitors in hypertension with left ventricular hypertrophy. Br Heart J (1994) 0.77
Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease. Cardiovasc Drugs Ther (1996) 0.76
Inhibition of angiotensin-converting enzyme by aqueous extract of tomato. Eur J Nutr (2014) 0.76
The Jeremiah Metzger Lecture. Pathogenesis of atherosclerosis: redox as a unifying mechanism. Trans Am Clin Climatol Assoc (2003) 0.76
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich) (2014) 0.76
Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors. J Thromb Thrombolysis (1995) 0.76
Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view. Heart (1996) 0.75
Angiotensin-converting enzyme inhibitors and coronary artery disease. Cardiovasc Drugs Ther (1996) 0.75
Role of ACE inhibitors in uncomplicated essential hypertension. Br Heart J (1994) 0.75
Risk factors: Plasma renin activity predicts renal impairment. Nat Rev Nephrol (2012) 0.75
A case of reninoma with variant angina. Kidney Res Clin Pract (2014) 0.75
Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits. Arterioscler Thromb Vasc Biol (2016) 0.75
Association between Dietary Sodium Intake and Cognitive Function in Older Adults. J Nutr Health Aging (2017) 0.75
Clinical Evidence: Emerging approaches in preventing cardiovascular disease. West J Med (1999) 0.75
Direct renin inhibition in chronic kidney disease. Br J Clin Pharmacol (2013) 0.75
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolization, arrhythmias, postmenopausal state and as anti-oxidants. Postgrad Med J (1994) 0.75
Renin and myocardial infarction in hypertension. N Engl J Med (1991) 0.75
Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients. Pak J Med Sci (2013) 0.75
Association of serum sodium concentration with coronary atherosclerosis in China: follow-up study. Acta Pharmacol Sin (2009) 0.75
John H. Laragh, MD: clinician-scientist. Am J Hypertens (2014) 0.75
Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.75
Higher plasma prorenin concentration plays a role in the development of coronary artery disease. Biomark Res (2015) 0.75
Sodium and Its Role in Cardiovascular Disease - The Debate Continues. Front Endocrinol (Lausanne) (2016) 0.75
Debate: Does it matter how you lower blood pressure? Curr Control Trials Cardiovasc Med (2000) 0.75
Genes of renin angiotensin system and coronary heart disease. Indian J Clin Biochem (2000) 0.75
Renin-sodium profile and the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 0.75
Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty. Intern Med (2016) 0.75
Fruitflow(®): the first European Food Safety Authority-approved natural cardio-protective functional ingredient. Eur J Nutr (2016) 0.75
New concepts regarding events that lead to myocardial infarction. Cardiovasc Drugs Ther (1995) 0.75
Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy. Drugs (1993) 0.75
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
How common is white coat hypertension? JAMA (1988) 4.42
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Renal function during antihypertensive treatment. Lancet (1995) 3.33
The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med (1996) 3.15
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst (1990) 2.72
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Residential segregation and mortality in New York City. Soc Sci Med (1998) 2.26
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Guidelines for the clinical use of red cell transfusions. Br J Haematol (2001) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG (2013) 2.16
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Methods for managing the increased workload in anticoagulant clinics. BMJ (1996) 2.03
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
Women, myocardial infarction, and dementia in the very old. Neurology (1990) 1.94
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med (1996) 1.88
Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration. Ann Surg (1991) 1.88
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest (1995) 1.85
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol (1998) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens (2002) 1.81
Botulinum toxin treatment of spasmodic torticollis. J R Soc Med (1992) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys (1987) 1.73
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg (1995) 1.71
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol (1997) 1.66
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol (1990) 1.65
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA (1989) 1.64
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension (1994) 1.63
Transfusion guidelines for neonates and older children. Br J Haematol (2004) 1.61
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens (1988) 1.60
Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet (1997) 1.60
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry (1998) 1.60